This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Contraindications

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • acute febrile illness - immunisation should be postponed
  • meningococcal vaccines should not be given to those who have had:
    • a confirmed anaphylactic reaction to a previous dose of the vaccine
    • a confirmed anaphylactic reaction to any constituent of the vaccine including meningococcal polysaccharide, diphtheria toxoid or the CRM197 carrier protein, or tetanus toxoid

Confirmed anaphylaxis after immunisation is extremely rare with anaphylactoid reactions reported approximately one in every 500,000 doses

Other allergic conditions, such as rashes, may occur more commonly and are not contraindications to further immunisation

Where there is doubt, appropriate advice should be sought from a consultant paediatrician, immunisation co-ordinator or consultant in communicable disease control rather than withhold immunisation

Reference:

  1. Immunisation Against Infectious Disease - "The Green Book".Chapter 22 meningococcal (August 2006)

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.